International expert group collaboration for developing an adverse outcome pathway for radiation induced leukemia

References

• Alexander BJ, Rasko JE, Morahan G, Cook WD. 1995. Gene deletion explains both in vivo and in vitro generated chromosome 2 aberrations associated with murine myeloid leukemia. Leukemia. 9(12):2009–2015.
   PubMed Web of Science ®Google Scholar
• Allen TE, Goodman JM, Gutsell S, Russell PJ. 2014. Defining molecular initiating events in the adverse outcome pathway framework for risk. Chem Res Toxicol. 27(12):2100–2112.
   PubMed Web of Science ®Google Scholar
• Alloni D, Cutaia C, Mariotti L, Friedland W, Ottolenghi A. 2014. Modeling dose deposition and DNA damage due to low-energy β(-) emitters. Radiat Res. 182(3):322–330.
   PubMed Web of Science ®Google Scholar
• Anglesio MS, Papadopoulos N, Ayhan A, Nazeran TM, Noe M, Horlings HM, Lum A, Jones S, Senz J, Seckin T, et al. 2017. Cancer-associated mutations in endometriosis without cancer. N Engl J Med. 376(19):1835–1848.
   PubMed Web of Science ®Google Scholar
• Babineau J. 2014. Product review: covidence (systematic review software). J Can Health Libr Assoc. 35(2):68–71.
   Google Scholar
• Bai J, Wang Y, Wang J, Zhai J, He F, Zhu G. 2020. Irradiation-induced senescence of bone marrow mesenchymal stem cells aggravates osteogenic differentiation dysfunction via paracrine signaling. Am J Physiol Cell Physiol. 318(5):C1005–C1017.
   PubMed Web of Science ®Google Scholar
• Boice JD, Jr., Cohen SS, Mumma MT, Ellis ED. 2022. The Million Person Study, whence it came and why. Int J Radiat Biol. 98(4):537–550.
   PubMed Web of Science ®Google Scholar
• Bouffler SD, Meijne EI, Morris DJ, Papworth D. 1997. Chromosome 2 hypersensitivity and clonal development in murine radiation acute myeloid leukaemia. Int J Radiat Biol. 72(2):181–189.
   PubMed Web of Science ®Google Scholar
• Bouville A, Toohey RE, Boice JD, Jr., Beck HL, Dauer LT, Eckerman KF, Hagemeyer D, Leggett RW, Mumma MT, Napier B, et al. 2015. Dose reconstruction for the million worker study: status and guidelines. Health Phys. 108(2):206–220.
   PubMed Web of Science ®Google Scholar
• Brown NL, Finnon R, Bulman RA, Finnon P, Moody J, Bouffler SD, Badie C. 2011. Sfpi1/PU.1 mutations in mouse radiation-induced acute myeloid leukaemias affect mRNA and protein abundance and associate with disrupted transcription. Leuk Res. 35(1):126–132.
   PubMed Web of Science ®Google Scholar
• Brown N, Finnon R, Manning G, Bouffler S, Badie C. 2015. Influence of radiation quality on mouse chromosome 2 deletions in radiation-induced acute myeloid leukaemia. Mutat Res Genet Toxicol Environ Mutagen. 793:48–54.
   PubMed Web of Science ®Google Scholar
• Bullinger L, Dohner K, Dohner H. 2017. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 35(9):934–946.
   PubMed Web of Science ®Google Scholar
• Camacho V, Kuznetsova V, Welner RS. 2021. Inflammatory cytokines shape an altered immune response during myeloid malignancies. Front Immunol. 12:772408.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Beaton D, Hamada N, Wilkins R, Burtt J, Leblanc J, Cool D, Garnier-Laplace J, Laurier D, Le Y, et al. 2022. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research. Int J Radiat Biol. 1–10.
   Web of Science ®Google Scholar
• Chauhan V, Hamada N, Monceau V, Ebrahimian T, Adam N, Wilkins RC, Sebastian S, Patel ZS, Huff JL, Simonetto C, et al. 2021. Expert consultation is vital for adverse outcome pathway development: a case example of cardiovascular effects of ionizing radiation. Int J Radiat Biol. 97(11):1516–1525.
   PubMed Web of Science ®Google Scholar
• Chauhan V, Said Z, Daka J, Sadi B, Bijlani D, Marchetti F, Beaton D, Gaw A, Li C, Burtt J, et al. 2019. Is there a role for the adverse outcome pathway framework to support radiation protection? Int J Radiat Biol. 95(2):225–232.
   PubMed Web of Science ®Google Scholar
• Cheek DM, Naxerova K. 2022. Mapping the long road to cancer. Cell. 185(6):939–940.
   PubMed Web of Science ®Google Scholar
• Christiansen DH, Andersen MK, Pedersen-Bjergaard J. 2001. Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis. JCO. 19(5):1405–1413.
   PubMed Web of Science ®Google Scholar
• Cook WD, McCaw BJ, Herring C, John DL, Foote SJ, Nutt SL, Adams JM. 2004. PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain. Blood. 104(12):3437–3444.
   PubMed Web of Science ®Google Scholar
• Coombs CC, Zehir A, Devlin SM, Kishtagari A, Syed A, Jonsson P, Hyman DM, Solit DB, Robson ME, Baselga J, et al. 2017. Therapy-related clonal hematopoiesis in patients with non-hematologic cancers is common and associated with adverse clinical outcomes. Cell Stem Cell. 21(3):374–382 e374.
   PubMed Web of Science ®Google Scholar
• Darakhshan F, Badie C, Moody J, Coster M, Finnon R, Finnon P, Edwards AA, Szluinska M, Skidmore CJ, Yoshida K, et al. 2006. Evidence for complex multigenic inheritance of radiation AML susceptibility in mice revealed using a surrogate phenotypic assay. Carcinogenesis. 27(2):311–318.
   PubMed Web of Science ®Google Scholar
• Dekkers F, Bijwaard H, Bouffler S, Ellender M, Huiskamp R, Kowalczuk C, Meijne E, Sutmuller M. 2011. A two-mutation model of radiation-induced acute myeloid leukemia using historical mouse data. Radiat Environ Biophys. 50(1):37–45.
   PubMed Web of Science ®Google Scholar
• Ding L, Ley TJ, Larson DE, Miller CA, Koboldt DC, Welch JS, Ritchey JK, Young MA, Lamprecht T, McLellan MD, et al. 2012. Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 481(7382):506–510.
   PubMed Web of Science ®Google Scholar
• Dohner H, Weisdorf DJ, Bloomfield CD. 2015. Acute myeloid leukemia. N Engl J Med. 373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Finnon R, Brown N, Moody J, Badie C, Olme CH, Huiskamp R, Meijne E, Sutmuller M, Rosemann M, Bouffler SD. 2012. Flt3-ITD mutations in a mouse model of radiation-induced acute myeloid leukaemia. Leukemia. 26(6):1445–1446.
   PubMed Web of Science ®Google Scholar
• Fleenor CJ, Marusyk A, DeGregori J. 2010. Ionizing radiation and hematopoietic malignancies: altering the adaptive landscape. Cell Cycle. 9(15):3005–3011.
   PubMed Web of Science ®Google Scholar
• Folley JH, Borges W, Yamawaki T. 1952. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med. 13(3):311–321.
   PubMed Web of Science ®Google Scholar
• Gault N, Verbiest T, Badie C, Romeo PH, Bouffler S. 2019. Hematopoietic stem and progenitor cell responses to low radiation doses - implications for leukemia risk. Int J Radiat Biol. 95(7):892–899.
   PubMed Web of Science ®Google Scholar
• Genovese G, Kahler AK, Handsaker RE, Lindberg J, Rose SA, Bakhoum SF, Chambert K, Mick E, Neale BM, Fromer M, et al. 2014. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 371(26):2477–2487.
   PubMed Web of Science ®Google Scholar
• Gomolka M, Blyth B, Bourguignon M, Badie C, Schmitz A, Talbot C, Hoeschen C, Salomaa S. 2020. Potential screening assays for individual radiation sensitivity and susceptibility and their current validation state. Int J Radiat Biol. 96(3):280–296.
   PubMed Web of Science ®Google Scholar
• Goodhead DT. 1994. Initial events in the cellular effects of ionizing radiations: clustered damage in DNA. Int J Radiat Biol. 65(1):7–17.
   PubMed Web of Science ®Google Scholar
• Hellmich C, Moore JA, Bowles KM, Rushworth SA. 2020. Bone marrow senescence and the microenvironment of hematological malignancies. Front Oncol. 10:230.
   PubMed Web of Science ®Google Scholar
• Henry CJ, Marusyk A, DeGregori J. 2011. Aging-associated changes in hematopoiesis and leukemogenesis: what’s the connection? Aging (Albany NY). 3(6):643–656.
   PubMedGoogle Scholar
• Hepburn M, Doherty I, Briscoe C, Riches A. 1987. Transplantation and morphological studies of primary and passaged murine radiation-induced myeloid leukaemias. Leuk Res. 11(11):1001–1009.
   PubMed Web of Science ®Google Scholar
• Hsu WL, Preston DL, Soda M, Sugiyama H, Funamoto S, Kodama K, Kimura A, Kamada N, Dohy H, Tomonaga M, et al. 2013. The incidence of leukemia, lymphoma and multiple myeloma among atomic bomb survivors: 1950–2001. Radiat Res. 179(3):361–382.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG, Lindsley RC, Mermel CH, Burtt N, Chavez A, et al. 2014. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 371(26):2488–2498.
   PubMed Web of Science ®Google Scholar
• Juliusson G, Lehmann S, Lazarevic V. 2021. Epidemiology and etiology of AML. In: Röllig C, Ossenkoppele GJ, editors. Acute myeloid leukemia. Cham: Springer International Publishing; p. 1–22.
   Google Scholar
• Karabulutoglu M, Finnon R, Cruz-Garcia L, Hill MA, Badie C. 2021. Oxidative stress and x-ray exposure levels-dependent survival and metabolic changes in murine HSPCs. Antioxidants (Basel). 11(1):11.
   PubMedGoogle Scholar
• Karabulutoglu M, Finnon R, Imaoka T, Friedl AA, Badie C. 2019. Influence of diet and metabolism on hematopoietic stem cells and leukemia development following ionizing radiation exposure. Int J Radiat Biol. 95(4):452–479.
   PubMed Web of Science ®Google Scholar
• Karlic H, Herrmann H, Varga F, Thaler R, Reitermaier R, Spitzer S, Ghanim V, Blatt K, Sperr WR, Valent P, et al. 2014. The role of epigenetics in the regulation of apoptosis in myelodysplastic syndromes and acute myeloid leukemia. Crit Rev Oncol Hematol. 90(1):1–16.
   PubMed Web of Science ®Google Scholar
• Khaldoyanidi S, Nagorsen D, Stein A, Ossenkoppele G, Subklewe M. 2021. Immune biology of acute myeloid leukemia: implications for immunotherapy. J Clin Oncol. 39(5):419–432.
   PubMed Web of Science ®Google Scholar
• Klymenko SV, Bink K, Trott KR, Bebeshko VG, Bazyka DA, Dmytrenko IV, Abramenko IV, Bilous NI, Zitzelsberger H, Misurin AV, et al. 2005. MLL gene alterations in radiation-associated acute myeloid leukemia. Exp Oncol. 27(1):71–75.
   PubMed Web of Science ®Google Scholar
• Klymenko S, Trott K, Atkinson M, Bink K, Bebeshko V, Bazyka D, Dmytrenko I, Abramenko I, Bilous N, Misurin A, et al. 2005. Aml1 gene rearrangements and mutations in radiation-associated acute myeloid leukemia and myelodysplastic syndromes. J Radiat Res. 46(2):249–255.
   PubMed Web of Science ®Google Scholar
• Kozbenko T, Adam N, Lai V, Sandhu S, Kuan J, Flores D, Appleby M, Parker H, Hocking R, Tsaioun K, et al. 2022. Deploying elements of scoping review methods for Adverse Outcome Pathway development: a space travel case example. Int J Radiat Biol. Submitted. 1–12.
   Google Scholar
• Larrue C, Heydt Q, Saland E, Boutzen H, Kaoma T, Sarry JE, Joffre C, Recher C. 2019. Oncogenic KIT mutations induce STAT3-dependent autophagy to support cell proliferation in acute myeloid leukemia. Oncogenesis. 8(8):39.
   PubMedGoogle Scholar
• Leuraud K, Richardson DB, Cardis E, Daniels RD, Gillies M, O'Hagan JA, Hamra GB, Haylock R, Laurier D, Moissonnier M, et al. 2015. Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol. 2(7):e276–e281.
   PubMed Web of Science ®Google Scholar
• Lo Coco F, Pisegna S, Diverio D. 1997. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias. Haematologica. 82(3):364–370.
   PubMed Web of Science ®Google Scholar
• Loh PR, Genovese G, Handsaker RE, Finucane HK, Reshef YA, Palamara PF, Birmann BM, Talkowski ME, Bakhoum SF, McCarroll SA, et al. 2018. Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations. Nature. 559(7714):350–355.
   PubMed Web of Science ®Google Scholar
• Lomax ME, Folkes LK, O'Neill P. 2013. Biological consequences of radiation-induced DNA damage: relevance to radiotherapy. Clin Oncol (R Coll Radiol). 25(10):578–585.
   PubMed Web of Science ®Google Scholar
• Major IR. 1979. Induction of myeloid leukaemia by whole-body single exposure of CBA male mice to x-rays. Br J Cancer. 40(6):903–913.
   PubMed Web of Science ®Google Scholar
• Marusyk A, Casas-Selves M, Henry CJ, Zaberezhnyy V, Klawitter J, Christians U, DeGregori J. 2009. Irradiation alters selection for oncogenic mutations in hematopoietic progenitors. Cancer Res. 69(18):7262–7269.
   PubMed Web of Science ®Google Scholar
• McNerney ME, Godley LA, Le Beau MM. 2017. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 17(9):513–527.
   PubMed Web of Science ®Google Scholar
• Meldrum RA, Mole RH. 1982. Radiation-induced myeloid leukaemia in CBA/H mice: a non-immunogenic malignant disease in syngeneic mice. Br J Cancer. 45(3):403–412.
   PubMed Web of Science ®Google Scholar
• NCRP Report 171. 2012. Uncertainties in the estimation of radiation risks and probability of disease causation. Bethesda (MD): NCRP.
   Google Scholar
• NCRP Report 186. 2020. Approaches for integrating information from radiation biology and epidemology to enhance low-dose health risk assessments. Bethesda (MD): NCRP.
   Google Scholar
• O'Brien G, Cruz-Garcia L, Zyla J, Brown N, Finnon R, Polanska J, Badie C. 2020. Kras mutations and PU.1 promoter methylation are new pathways in murine radiation-induced AML. Carcinogenesis. 41(8):1104–1112.
   PubMed Web of Science ®Google Scholar
• Olme CH, Brown N, Finnon R, Bouffler SD, Badie C. 2013. Frequency of acute myeloid leukaemia-associated mouse chromosome 2 deletions in X-ray exposed immature haematopoietic progenitors and stem cells. Mutat Res. 756(1–2):119–126.
   PubMed Web of Science ®Google Scholar
• Olme CH, Finnon R, Brown N, Kabacik S, Bouffler SD, Badie C. 2013. Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia. Leuk Res. 37(10):1374–1382.
   PubMed Web of Science ®Google Scholar
• Patel A, Anderson J, Kraft D, Finnon R, Finnon P, Scudamore CL, Manning G, Bulman R, Brown N, Bouffler S, et al. 2016. The influence of the CTIP polymorphism, Q418P, on homologous recombination and predisposition to radiation-induced tumorigenesis (mainly rAML) in mice. Radiat Res. 186(6):638–649.
   PubMed Web of Science ®Google Scholar
• Pedersen-Bjergaard J, Philip P, Larsen SO, Andersson M, Daugaard G, Ersboll J, Hansen SW, Hou-Jensen K, Nielsen D, Sigsgaard TC. 1993. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series. Leukemia. 7(12):1975–1986.
   PubMed Web of Science ®Google Scholar
• Peng Y, Brown N, Finnon R, Warner CL, Liu X, Genik PC, Callan MA, Ray FA, Borak TB, Badie C, et al. 2009. Radiation leukemogenesis in mice: loss of PU.1 on chromosome 2 in CBA and C57BL/6 mice after irradiation with 1 GeV/nucleon 56Fe ions, X rays or gamma rays. Part I. Experimental observations. Radiat Res. 171(4):474–483.
   PubMed Web of Science ®Google Scholar
• Poluben L, Puligandla M, Neuberg D, Bryke CR, Hsu Y, Shumeiko O, Yuan X, Voznesensky O, Pihan G, Adam M, et al. 2019. Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident. Am J Hematol. 94(1):62–73.
   PubMed Web of Science ®Google Scholar
• Preston RJ, Ruhm W, Azzam EI, Boice JD, Bouffler S, Held KD, Little MP, Shore RE, Shuryak I, Weil MM. 2021. Adverse outcome pathways, key events, and radiation risk assessment. Int J Radiat Biol. 97(6):804–814.
   PubMed Web of Science ®Google Scholar
• Rassool FV, Gaymes TJ, Omidvar N, Brady N, Beurlet S, Pla M, Reboul M, Lea N, Chomienne C, Thomas NS, et al. 2007. Reactive oxygen species, DNA damage, and error-prone repair: a model for genomic instability with progression in myeloid leukemia? Cancer Research. 67(18):8762–8771.
   PubMed Web of Science ®Google Scholar
• Riley PA. 1994. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol. 65(1):27–33.
   PubMed Web of Science ®Google Scholar
• Rithidech KN, Cronkite EP, Bond VP. 1999. Advantages of the CBA mouse in leukemogenesis research. Blood Cells Mol Dis. 25(1):38–45.
   PubMed Web of Science ®Google Scholar
• Rothkamm K, Kruger I, Thompson LH, Lobrich M. 2003. Pathways of DNA double-strand break repair during the mammalian cell cycle. Mol Cell Biol. 23(16):5706–5715.
   PubMed Web of Science ®Google Scholar
• Rubner Y, Wunderlich R, Ruhle PF, Kulzer L, Werthmoller N, Frey B, Weiss EM, Keilholz L, Fietkau R, Gaipl US. 2012. How does ionizing irradiation contribute to the induction of anti-tumor immunity? Front Oncol. 2:75.
   PubMedGoogle Scholar
• Sabin RJ, Anderson RM. 2011. Cellular Senescence - its role in cancer and the response to ionizing radiation. Genome Integr. 2(1):7.
   PubMedGoogle Scholar
• Schuringa JJ, Bonifer C. 2020. Dissecting clonal heterogeneity in AML. Cancer Cell. 38(6):782–784.
   PubMed Web of Science ®Google Scholar
• Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM. 2019. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges. Blood Rev. 36:70–87.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA A Cancer J Clin. 69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Silver A, Moody J, Dunford R, Clark D, Ganz S, Bulman R, Bouffler S, Finnon P, Meijne E, Huiskamp R, et al. 1999. Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12. Genes Chromosom Cancer. 24(2):95–104.
   PubMed Web of Science ®Google Scholar
• Smith SM, Le Beau MM, Huo D, Karrison T, Sobecks RM, Anastasi J, Vardiman JW, Rowley JD, Larson RA. 2003. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood. 102(1):43–52.
   PubMed Web of Science ®Google Scholar
• Steensma DP. 2018. Clinical consequences of clonal hematopoiesis of indeterminate potential. Blood Adv. 2(22):3404–3410.
   PubMed Web of Science ®Google Scholar
• Stouten S, Verduyn Lunel S, Finnon R, Badie C, Dekkers F. 2021. Modeling low-dose radiation-induced acute myeloid leukemia in male CBA/H mice. Radiat Environ Biophys. 60(1):49–60.
   PubMed Web of Science ®Google Scholar
• Super HJ, McCabe NR, Thirman MJ, Larson RA, Le Beau MM, Pedersen-Bjergaard J, Philip P, Diaz MO, Rowley JD. 1993. Rearrangements of the MLL gene in therapy-related acute myeloid leukemia in patients previously treated with agents targeting DNA-topoisomerase II. Blood. 82(12):3705–3711.
   PubMed Web of Science ®Google Scholar
• Takasugi M, Yoshida Y, Hara E, Ohtani N. 2022. The role of cellular senescence and SASP in tumour microenvironment. Febs J.
   PubMed Web of Science ®Google Scholar
• UNSCEAR 2021. Annex C. Biological mechanisms relevant for the inference of cancer risks from low-dose and low-dose-rate radiation UNSCEAR 2020/2021 report. Vienna: UNSCEAR.
   Google Scholar
• Verbiest T, Bouffler S, Nutt SL, Badie C. 2015. PU.1 downregulation in murine radiation-induced acute myeloid leukaemia (AML): from molecular mechanism to human AML. Carcinogenesis. 36(4):413–419.
   PubMed Web of Science ®Google Scholar
• Verbiest T, Finnon R, Brown N, Cruz-Garcia L, Finnon P, O'Brien G, Ross E, Bouffler S, Scudamore CL, Badie C. 2018. Tracking preleukemic cells in vivo to reveal the sequence of molecular events in radiation leukemogenesis. Leukemia. 32(6):1435–1444.
   PubMed Web of Science ®Google Scholar
• Vinken M. 2013. The adverse outcome pathway concept: a pragmatic tool in toxicology. Toxicology. 312:158–165.
   PubMed Web of Science ®Google Scholar
• Wang B, Kohli J, Demaria M. 2020. Senescent cells in cancer therapy: friends or foes? Trends Cancer. 6(10):838–857.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu L, Zhou D. 2011. Inhibition of p38 MAPK attenuates ionizing radiation-induced hematopoietic cell senescence and residual bone marrow injury. Radiat Res. 176(6):743–752.
   PubMed Web of Science ®Google Scholar
• Wild CP. 2005. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev. 14(8):1847–1850.
   PubMed Web of Science ®Google Scholar
• Wodnar-Filipowicz A, Kalberer CP. 2007. Function of natural killer cells in immune defence against human leukaemia. Swiss Med Wkly. 137 Suppl 155(Suppl 155):25S–30S.
   PubMedGoogle Scholar
• Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, Lamprecht TL, Shen D, Hundal J, Fulton RS, et al. 2015. Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia. Nature. 518(7540):552–555.
   PubMed Web of Science ®Google Scholar
• Yasinska IM, Goncalves Silva I, Sakhnevych S, Gibbs BF, Raap U, Fasler-Kan E, Sumbayev VV. 2018. Biochemical mechanisms implemented by human acute myeloid leukemia cells to suppress host immune surveillance. Cell Mol Immunol. 15(11):989–991.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Shao Q, Peng G. 2020. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment. Cell Mol Immunol. 17(1):27–35.
   PubMed Web of Science ®Google Scholar